AQR Capital Management
MDT icon

AQR Capital Management’s Medtronic MDT Stock Holding History

AQR Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$140M Sell
1,626,347
-1,442,757
-47% -$138M 0.06% 413
2025
Q4 		$295M Sell
3,069,104
-260,310
-8% -$25.3M 0.15% 162
2025
Q3 		$314M Buy
3,329,414
+1,350,888
+68% +$124M 0.2% 114
2025
Q2 		$172M Sell
1,978,526
-1,390,791
-41% -$118M 0.14% 191
2025
Q1 		$299M Buy
3,369,317
+762,632
+29% +$68.2M 0.31% 60
2024
Q4 		$208M Buy
2,606,685
+465,007
+22% +$40.3M 0.27% 68
2024
Q3 		$191M Buy
2,141,678
+696,547
+48% +$58.6M 0.26% 76
2024
Q2 		$113M Buy
1,445,131
+98,901
+7% +$8.11M 0.17% 144
2024
Q1 		$117M Buy
1,346,230
+279,739
+26% +$23.9M 0.2% 119
2023
Q4 		$87.9M Sell
1,066,491
-158,713
-13% -$12.1M 0.17% 141
2023
Q3 		$95.9M Buy
1,225,204
+149,425
+14% +$12.5M 0.2% 118
2023
Q2 		$94.8M Sell
1,075,779
-85,319
-7% -$7.35M 0.2% 115
2023
Q1 		$92.4M Sell
1,161,098
-597,237
-34% -$48.7M 0.2% 113
2022
Q4 		$136M Buy
1,758,335
+567,674
+48% +$46M 0.31% 60
2022
Q3 		$96.1M Buy
1,190,661
+101,072
+9% +$9.08M 0.23% 97
2022
Q2 		$97.5M Sell
1,089,589
-100,106
-8% -$10.1M 0.22% 105
2022
Q1 		$132M Sell
1,189,695
-177,515
-13% -$18.8M 0.25% 91
2021
Q4 		$141M Sell
1,367,210
-21,637
-2% -$2.51M 0.26% 86
2021
Q3 		$174M Sell
1,388,847
-13,230
-0.9% -$1.71M 0.32% 65
2021
Q2 		$174M Sell
1,402,077
-300,327
-18% -$37.7M 0.3% 71
2021
Q1 		$201M Sell
1,702,404
-58,706
-3% -$6.88M 0.33% 58
2020
Q4 		$204M Sell
1,761,110
-80,085
-4% -$8.82M 0.36% 52
2020
Q3 		$190M Sell
1,841,195
-660,431
-26% -$66.3M 0.32% 61
2020
Q2 		$223M Buy
2,501,626
+215,049
+9% +$20.6M 0.36% 57
2020
Q1 		$205M Sell
2,286,577
-589,212
-20% -$62.7M 0.35% 66
2019
Q4 		$324M Sell
2,875,789
-838,927
-23% -$92.1M 0.37% 66
2019
Q3 		$402M Sell
3,714,716
-704,963
-16% -$73.6M 0.47% 44
2019
Q2 		$430M Sell
4,419,679
-339,862
-7% -$31M 0.48% 37
2019
Q1 		$429M Buy
4,759,541
+1,822,331
+62% +$163M 0.46% 40
2018
Q4 		$267M Buy
2,937,210
+1,173,806
+67% +$110M 0.31% 85
2018
Q3 		$173M Buy
1,763,404
+552,207
+46% +$51.1M 0.17% 156
2018
Q2 		$104M Sell
1,211,197
-90,557
-7% -$7.56M 0.1% 237
2018
Q1 		$104M Buy
1,301,754
+401,665
+45% +$33.1M 0.11% 222
2017
Q4 		$72.7M Buy
900,089
+371,907
+70% +$29.8M 0.08% 298
2017
Q3 		$41.1M Sell
528,182
-203,992
-28% -$16.9M 0.05% 422
2017
Q2 		$65M Buy
732,174
+163,102
+29% +$13.8M 0.09% 301
2017
Q1 		$45.8M Sell
569,072
-269,268
-32% -$21M 0.06% 420
2016
Q4 		$59.7M Buy
838,340
+194,096
+30% +$15.2M 0.08% 325
2016
Q3 		$55.7M Buy
644,244
+148,976
+30% +$13M 0.09% 326
2016
Q2 		$43M Sell
495,268
-6,512
-1% -$527K 0.08% 358
2016
Q1 		$37.6M Buy
501,780
+76,602
+18% +$5.77M 0.07% 380
2015
Q4 		$32.7M Sell
425,178
-271,105
-39% -$20.4M 0.06% 428
2015
Q3 		$46.6M Sell
696,283
-468,553
-40% -$34.5M 0.09% 284
2015
Q2 		$86.3M Sell
1,164,836
-91,149
-7% -$6.96M 0.17% 166
2015
Q1 		$98M Sell
1,255,985
-167,844
-12% -$12.7M 0.22% 128
2014
Q4 		$103M Buy
1,423,829
+25,831
+2% +$1.79M 0.22% 135
2014
Q3 		$86.6M Sell
1,397,998
-1,468,127
-51% -$93.3M 0.24% 112
2014
Q2 		$183M Sell
2,866,125
-64,500
-2% -$3.92M 0.49% 32
2014
Q1 		$180M Buy
2,930,625
+52,182
+2% +$3.04M 0.54% 27
2013
Q4 		$165M Buy
2,878,443
+305,880
+12% +$17.3M 0.49% 31
2013
Q3 		$137M Buy
2,572,563
+305,948
+13% +$16.5M 0.48% 33
2013
Q2 		$117M Buy
+2,266,615
New +$112M 0.41% 40

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management's MDT Position: Q1 2026 in Review

AQR Capital Management reduced its Medtronic (MDT) stake by 47% in Q1 2026, selling an estimated $138M and leaving 1,626,347 shares worth $140M. The position accounts for 0.06% of the portfolio, ranked #413.

AQR Capital Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $430M in Q2 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • AQR Capital Management held 1,626,347 shares of Medtronic worth $140M as of Q1 2026.
  • AQR Capital Management sold 1,442,757 Medtronic shares in Q1 2026, an estimated $138M.
  • Medtronic made up 0.06% of AQR Capital Management's portfolio in Q1 2026, its #413 holding.
  • AQR Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • AQR Capital Management's Medtronic position peaked at $430M in Q2 2019.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.